OOIR: Observatory of International Research

Papers

(The TQCC of Pediatric Rheumatology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Predictors of fibrogenesis in children with JIA: a single-center pilot study	44
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial	43
Clinical features, treatment, and outcomes of celiac-associated arthritis: a retrospective cohort study	37
Algorithmic approach in the diagnosis of pediatric uveitis	37
The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource	31
Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus	26
Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis	26
Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators	24
Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC)	24
Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study	22
Musculoskeletal symptoms and their impact on health-related quality of life in chronic nonbacterial osteomyelitis patients	22
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives	20
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis	20
Experiences of sexual and reproductive health screening and counseling in the clinical setting among adolescents and young adults with rheumatic disease	19
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience	18
Therapeutic recreation camps for youth with childhood-onset systemic lupus erythematosus: perceived psychosocial benefits	18
Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort	17
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study	17
Proceedings of the 29th European Paediatric Rheumatology Congress	17
Relationship of regional ultraviolet index data with rash and systemic disease activity in youth with childhood-onset systemic lupus: results from the Childhood Arthritis and Rheumatology Research All	16
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication	16
A randomized controlled educational study to evaluate an e-learning module to teach the physical examination of the temporomandibular joint in juvenile idiopathic arthritis	16
Natural autoimmunity in oligoarticular juvenile idiopathic arthritis	16
The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients	15
Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals	15

Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis	15
Investigating the association between SARS-CoV-2 infection, COVID-19 vaccination, and autoimmune diseases in a pediatric population: a comprehensive analysis	14
Translating research into practice—implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retr	14
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study	14
Body mass index is associated with health-related quality of life and disease characteristics in young adults with juvenile idiopathic arthritis	14
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (S	14
Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study	14
Clinical and genetic characteristics of PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome	14
Pediatric immune-mediated necrotizing myopathy with anti-SRP antibodies targeting 19, 68, and 72 kda subunits	14
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge	14
Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center	14
Correction: PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	14
Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry	13
Exploring paediatric rheumatology care: a ten-year retrospective analysis of the patient population in Ghana	13
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis	13
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis	13
Cytokines in saliva, serum, and temporomandibular joint synovial fluid in children with juvenile idiopathic arthritis: An explorative cross-sectional study	13
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice	13
14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report	13
Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature	13
Feasibility of quantitative sensory testing in juvenile idiopathic arthritis	12
Exploring the clinical profiles and management of juvenile dermatomyositis in Africa: a survey of African rheumatology care providers	12
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report	12
Long noncoding RNAs (CTC-471J1.2, NeST) as epigenetic risk factors of active juvenile lupus nephritis: a case-control study	12
How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience	12
An iceberg I can’t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya	11
Tapering of biological treatment in autoinflammatory diseases: a scoping review	11
Circulating prolactin level in Juvenile Systemic Lupus Erythematosus and its correlation with disease activity: a case control study	11
Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis	11
Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report	11
Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review	11
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases	11
Screening for celiac disease in juvenile idiopathic arthritis	11
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort	11
Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis	11
Differences between leukemic arthritis and juvenile idiopathic arthritis	11
Longitudinal assessment of preparation for care transition among adolescents and young adults with rheumatologic disease: a single-center pilot study	10
A virtual pediatric rheumatology teaching initiative for physicians in Somaliland	10
Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms	10
Epstein–Barr Virus encephalitis associated hemophagocytic lymphohistiocytosis in childhood-onset systemic lupus erythematosus: a case-based review	10
Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review	10
Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance	10
NLRP12-associated systemic autoinflammatory diseases in children	10
A novel PRKDC mutation caused B lymphocytes V(D)J rearrangement disorder in the SLE-DAH like symptoms patient	10
Chronic non-bacterial osteomyelitis in children- five-year standardized follow-up of a prospective observational cohort in the pre-biological era	10
Monogenic disorders as mimics of juvenile idiopathic arthritis	9
Structural ultrasound of joints and tendons in healthy children: development of normative data	9
Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients	9
Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain	9
Kawasaki disease in Kenya and review of the African literature	9

Restricted upper airway dimensions in patients with dentofacial deformity from juvenile idiopathic arthritis	9
A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences	9
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases	9
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis	8
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study	8
High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong	8
Bone health and physical activity in adolescents with juvenile idiopathic arthritis: a cross-sectional case-control study	8
Correction: Transition readiness among finnish adolescents with juvenile idiopathic arthritis	8
Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis	8
MicroRNA-27a-3p enhances the inflammatory phenotype of Juvenile Idiopathic Arthritis fibroblast-like synoviocytes	8
Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud’s phenomenon	8
Assay for interferon gamma release as a novel marker in pediatric patients with systemic lupus erythematosus	8
Hypertension as a prominent manifestation secondary to renal artery lesions in pediatric Behcet’s disease	8
Depression and anxiety in childhood-onset systemic lupus erythematosus: prevalence, associated factors, and impact on quality of life and family	8
Characterizing lupus in African American children in Southern United States	8
Whole-exome sequencing analysis identifies novel variants associated with Kawasaki disease susceptibility	8
Paediatric autoimmune diseases with ELANE mutations associated with neutropenia	7
Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination	7
Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis	7
Axial involvement in enthesitis-related arthritis: results from a single-center cohort	7
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data	7
Correction: Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases	7
Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes	7
Panniculitis with late onset enthesitis-related arthritis: a case report	7
Transition readiness in adolescents and young adults with chronic rheumatic disease in Oman: today’s needs and future challenges	7
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research	7
Feasibility of applying infrared thermal imaging for home monitoring of arthritis in children	7
Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor	7
Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report	7
ANCA-negative eosinophilic granulomatosis with polyangiitis in a girl misdiagnosed as asthma and pulmonary tuberculosis	7
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe	7
Towards a histological diagnosis of childhood small vessel CNS vasculitis	7
Scurvy masquerading as IgA vasculitis	7
Pain-coping scale for children and their parents: a cross-sectional study in children with musculoskeletal pain	7
Is an association of acro-osteolysis, bone fragility, and enchondromatosis a newfound disease caused by an amplification of PTHLH? A case report	7
High rheumatoid factor does not diminish efficacy of TNF inhibitors in seropositive JIA	7
Infections and antibiotics during fetal life and childhood and their relationship to juvenile idiopathic arthritis: a prospective cohort study	7
Kawasaki disease with an asymptomatic reversible splenial lesion	6
Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort	6
What have we learned from long-term studies in juvenile idiopathic arthritis? – Prediction, classification, transition.	6
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature	6
PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	6
Unveiling the uncommon: diagnostic journey of camurati-engelmann disease in a pediatric patient	6
An updated overview of Juvenile systemic sclerosis in a French cohort	6
Effect of exercise training on heath, quality of life, exercise capacity in juvenile idiopathic arthritis: a meta-analysis of randomized controlled trials	6
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis	6
Bacterial infection in patients with juvenile systemic lupus erythematosus and fever	6
Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry	6
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series	6
Prevalence of spine pain among Tunisian children and adolescents and related factors	6
Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease	6
Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study	6
Accuracy and adequacy of photoprotection in pediatric systemic lupus erythematosus patients, and the effect of education on photoprotection: a prospective study	6
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors	6